Published in AIDS Weekly, August 5th, 1996
Dr. Julian Gold, Prince of Wales Hospital, Sydney, and colleagues evaluated nandrolone decanoate in a group of HIV positive men "who had lost 5-15 percent of their usual body weight" and who were resistant to nutritional intervention. In this 16-week open trial, nandrolone decanoate was administered by IM injection every two weeks at a dose of 100 mg/ml.
In the June 1996 issue of AIDS, Gold reported that nandrolone...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.